Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyAlison Stopeck, Ada Braun, Allan Lipton et al.|Journal of Clinical Oncology|2010Cited by 1.6k
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast CancerDavid Miles, Gilles Romieu, Joohyuk Sohn et al.|Journal of Clinical Oncology|2010Cited by 887
Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposureJean‐Jacques Body, Karim Fizazi, Julie R. Gralow et al.|Journal of Bone and Mineral Research|2009Cited by 120
2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 studyAlison Stopeck, J.J. Body, Yasuyuki Fujiwara et al.|European Journal of Cancer Supplements|2009Cited by 84